The present invention relates to methods and compositions for the
treatment and/or prevention of neuropathological and/or neurodegenerative
diseases. In particular, the invention delivers novel uses of inhibitors
of Urokinase-type Plasminogen activator in the treatment of amyotrophic
lateral sclerosis.